Pharmaceutical giant Mylan Inc (NASDAQ:MYL) is eyeing the potential acquisition of rival Meda, according to inside sources. Meda Chairman Bert-Ake Eriksson confirmed that MYL had made “preliminary contact,” but said further details would have to wait until later today. Mylan Inc (NASDAQ:MYL) stock opened today at $53.00 and is currently trading at $52.93. The stock showed a positive weekly performance of 2.63%.
Micron Technology, Inc. (NASDAQ:MU) improved its financial strength with increasing return on equity (ROE) compared to prior year periods. The Company’s ROE is above the industry average within the Semiconductors & Semiconductor Equipment industry. Micron Technology, Inc. (NASDAQ:MU) stock opened at $24.80, in current trading session and currently is at $24.65, by gaining 2.83%. The 52 week range of $`9.04-$25.68. Company’s market capitalization is $26.02 billion.
Halozyme Therapeutics Inc. (NASDAQ: HALO) will need some therapeutics of its own, as are its shareholders. Its shares got pounded Friday morning on news of a temporary halt of its Phase II trial enrollment and dosing for its pancreatic cancer study. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock is currently trading at $8.35 .The EPS of the stock is -0.74. Company’s market capitalization is $1.01 billion.
In spite of its rival, Facebook’s (NASDAQ:FB) latest declaration that it’s purchasing WhatsApp, a multi-platform messaging service, in a deal priced at a jaw-dropping $19 billion, Facebook seemingly still has plans for its challenging Messenger app. In a latest update to the app, Facebook modernized its group chatting but investors seemed disappointed and shares were down -4% during Thursday session. Facebook Inc (NASDAQ:FB) stock opened the session at $59.97, and now is at $59.70. The 52 week range of the FB stock remained $22.67-$72.59 and the day range was $59.71-$60.20.
Leave a Reply